Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Biopharmaceutics & Drug Disposition|September 1, 1987
Phenylpropanolamine pharmacokinetics in dogs after intravenous, oral, and oral controlled-release dosesM A Hussain, B J Aungst, G Lam, et al.
Journal of Pharmaceutical Sciences|September 1, 1990
Nasal administration of a cognition enhancer provides improved bioavailability but not enhanced brain deliveryM A Hussain, D Rakestraw, S Rowe, et al.
Journal of Pharmaceutical Sciences|January 10, 1998
Intranasal absorption of the platelet glycoprotein IIb/IIIa receptor antagonist, DMP 755, and the effect of anesthesia on nasal bioavailabilityM A Hussain, B J Aungst, R Kapil, et al.
Pharmaceutical Research|September 1, 1988
Improved buccal delivery of opioid analgesics and antagonists with bitterless prodrugsM A Hussain, B J Aungst, C A Koval, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 18, 2000
Region-dependent disappearance of vinblastine in rat small intestine and characterization of its P-glycoprotein-mediated efflux systemA Nakayama, H Saitoh, M Oda, et al.
Journal of Pharmaceutical Sciences|May 1, 1990
Recovery of rat nasal mucosa from the effects of aminopeptidase inhibitorsM A Hussain, C A Koval, A B Shenvi, et al.
Life Sciences|January 1, 1990
An aminoboronic acid derivative inhibits thymopentin metabolism by mucosal membrane aminopeptidasesM A Hussain, C A Koval, A B Shenvi, et al.
Pharmaceutical Research|January 6, 2001
The influence of donor and reservoir additives on Caco-2 permeability and secretory transport of HIV protease inhibitors and other lipophilic compoundsB J Aungst, N H Nguyen, J P Bulgarelli, et al.
Pharmaceutical Research|February 1, 1996
Effects of structural modifications on the intestinal permeability of angiotensin II receptor antagonists and the correlation of in vitro, in situ, and in vivo absorptionM D Ribadeneira, B J Aungst, C J Eyermann, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1990
Effects of plasma protein binding displacement on the pharmacokinetics, tissue and tumor concentrations and efficacy of brequinar, a highly protein-bound antitumor agentB J Aungst, J A Blake, N J Rogers, et al.
Pageof 4